A Study Comparing the MAGICTouch™ Sirolimus-coated Balloon With a Paclitaxel-coated Balloon for Treating Severe Narrowing or Blockage in the Femoropopliteal Arteries.
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 478 participants.
Also called NCT07359807
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 478 participants
- Sponsor
- Registry
-
NCT07359807
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07359807. Randomized; double masking; primary purpose treatment. Start 2026-04 (anticipated); primary completion 2027-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study Comparing the MAGICTouch™ Sirolimus-coated Balloon With a Paclitaxel-coated Balloon for Treating Severe Narrowing or Blockage in the Femoropopliteal Arteries.
- Acronym
- MAGICAL SFA
- Condition
- Popliteal Artery Disease
- Condition
- Superficial Femoral Artery Disease
- Intervention (Combination product)
- Sirolimus (RAPAMUNE) drug-coated balloon angioplasty catheter
- Intervention (Combination product)
- Paclitaxel drug-coated balloon angioplasty
- Lead sponsor
- Concept Medical Inc.
Record details
- Record id
cardio:ct-nct07359807- Content hash
89d1b324630a808c4155a987021cc1b1ec781a246ff0fc49b8f4a3a6e4432c80